RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.220
-0.020 (-1.61%)
May 20, 2025, 4:00 PM - Market closed
RenovoRx Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for RenovoRx stock ranges from a low of $3.00 to a high of $11. The average analyst price target of $7.00 forecasts a 473.77% increase in the stock price over the next year.
Price Target: $7.00 (+473.77%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RenovoRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +145.90% | May 19, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +801.64% | Apr 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +145.90% | Apr 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +145.90% | Mar 27, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.25 → $9 | Strong Buy | Maintains | $8.25 → $9 | +637.70% | Dec 10, 2024 |
Financial Forecast
Revenue This Year
1.73M
from 43.00K
Increased by 3,927.91%
Revenue Next Year
5.54M
from 1.73M
Increased by 219.75%
EPS This Year
-0.30
from -0.40
EPS Next Year
-0.24
from -0.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.2M | 6.3M | 29.2M | ||
| Avg | 1.7M | 5.5M | 20.3M | ||
| Low | 980,000 | 4.4M | 11.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5,016.3% | 263.7% | 426.5% | ||
| Avg | 3,927.9% | 219.7% | 266.2% | ||
| Low | 2,179.1% | 154.6% | 112.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.30 | -0.21 | 0.09 | ||
| Avg | -0.30 | -0.24 | -0.01 | ||
| Low | -0.29 | -0.26 | -0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.